Article Information
History
- August 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Christina Y. Lee1,2,
- Monika K. Shah2,3,
- David Hoyos4,
- Alexander Solovyov4,
- Melanie Douglas1,
- Ying Taur2,3,
- Peter G. Maslak5,6,
- N. Esther Babady3,7,
- Benjamin Greenbaum4,8,
- Mini Kamboj2,3,9 and
- Santosha A. Vardhana1,2,10,11,*
- 1Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 2Department of Medicine, Weill Cornell Medical College, Cornell University, New York, NY, USA
- 3Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 4Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 5Department of Medicine, Memorial Sloan Kettering Cancer Center
- 6Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center
- 7Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 8Physiology, Biophysics & Systems Biology, Weill Cornell Medicine, Weill Cornell Medical College, New York, NY, USA
- 9Infection Control, Division of Quality and Safety, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 10Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 11Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA
- ↵*Corresponding Author:
Santosha Vardhana (vardhans{at}mskcc.org)
Posted August 29, 2021.
